1ST Biotherapeutics and Merck to assess cancer combination treatment

1ST Biotherapeutics and Merck to assess cancer combination treatment

Submitted by admin on September 20, 2023 - 11:09pm
Source: 
Clinical Trials Arena
News Tags: 
Merck
1st Biotherapeutics
Keytruda
solid tumors
clinical trials
Headline: 
1ST Biotherapeutics and Merck to assess cancer combination treatment
snippet: 

Under the deal, FB849 plus Keytruda will be evaluated in a Phase I/II clinical trial for treating advanced solid tumour patients.

Do Not Allow Advertisers to Use My Personal information